Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Roche's Avastin Not as Good in New Studies as Early Data Showed, FDA Says
Roche's Avastin Not as Good in New Studies as Early Data Showed, FDA Says
Roche's Avastin Not as Good in New Studies as Early Data Showed, FDA Says
Submitted by
admin
on July 16, 2010 - 8:23am
Source:
Bloomberg
News Tags:
FDA
Avastin
Roche
breast cancer
Headline:
Roche's Avastin Not as Good in New Studies as Early Data Showed, FDA Says
Do Not Allow Advertisers to Use My Personal information
